參考文獻 |
1. Priller, C.; Bauer, T.; Mitteregger, G.; Krebs, B.; Kretzschmar, H. A.; Herms, J., Synapse formation and function is modulated by the amyloid precursor protein. Journal of Neuroscience 2006, 26 (27), 7212-7221.
2. Terry, R. D.; Masliah, E.; Salmon, D. P.; Butters, N.; DeTeresa, R.; Hill, R.; Hansen, L. A.; Katzman, R., Physical basis of cognitive alterations in Alzheimer′s disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991, 30 (4), 572-580.
3. Cárdenas-Aguayo, M. d. C.; Silva-Lucero, M. d. C.; Cortes-Ortiz, M.; Jiménez-Ramos, B.; Gómez-Virgilio, L.; Ramírez-Rodríguez, G.; Vera-Arroyo, E.; Fiorentino-Pérez, R.; García, U.; Luna-Muñoz, J., Physiological role of amyloid beta in neural cells: the cellular trophic activity. InTech 2014, 1-24.
4. McLaurin, J.; Yang, D.-S.; Yip, C.; Fraser, P., Review: modulating factors in amyloid-β fibril formation. Journal of Structural Biology 2000, 130 (2-3), 259-270.
5. Butterfield, S. M.; Lashuel, H. A., Amyloidogenic protein–membrane interactions: mechanistic insight from model systems. Angewandte Chemie International Edition 2010, 49 (33), 5628-5654.
6. Yanagisawa, K.; Odaka, A.; Suzuki, N.; Ihara, Y., GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer′s disease. Nature Medicine 1995, 1 (10), 1062-1066.
7. Sugiura, Y.; Ikeda, K.; Nakano, M., High membrane curvature enhances binding, conformational changes, and fibrillation of amyloid-β on lipid bilayer surfaces. Langmuir 2015, 31 (42), 11549-11557.
8. Ciccotosto, G. D.; Tew, D. J.; Drew, S. C.; Smith, D. G.; Johanssen, T.; Lal, V.; Lau, T.-L.; Perez, K.; Curtain, C. C.; Wade, J. D., Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity. Neurobiology of Aging 2011, 32 (2), 235-248.
9. Hung, L. W.; Ciccotosto, G. D.; Giannakis, E.; Tew, D. J.; Perez, K.; Masters, C. L.; Cappai, R.; Wade, J. D.; Barnham, K. J., Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity. Journal of Neuroscience 2008, 28 (46), 11950-11958.
10. Masters, C. L.; Selkoe, D. J., Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine 2012, 2 (6), a006262.
11. Lorenzo, A.; Yuan, M.; Zhang, Z.; Paganetti, P. A.; Sturchler-Pierrat, C.; Staufenbiel, M.; Mautino, J.; Vigo, F. S.; Sommer, B.; Yankner, B. A., Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer′s disease. Nature Neuroscience 2000, 3 (5), 460-464.
12. Jin, M.; Shepardson, N.; Yang, T.; Chen, G.; Walsh, D.; Selkoe, D. J., Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proceedings of the National Academy of Sciences 2011, 108 (14), 5819-5824.
13. Crouch, P. J.; White, A. R.; Bush, A. I., The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer′s disease. FEBS Journal 2007, 274 (15), 3775-3783.
14. Arispe, N.; Pollard, H. B.; Rojas, E., Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proceedings of the National Academy of Sciences 1993, 90 (22), 10573-10577.
15. Tofoleanu, F.; Buchete, N.-V., Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels. Prion 2012, 6 (4), 339-345.
16. Mouritsen, O. G., Lipids, curvature, and nano‐medicine. European Journal of Lipid Science and Technology 2011, 113 (10), 1174-1187.
17. Shah, J. C.; Sadhale, Y.; Chilukuri, D. M., Cubic phase gels as drug delivery systems. Advanced Drug Delivery Reviews 2001, 47 (2), 229-250.
18. Torchilin, V. P., Multifunctional nanocarriers. Advanced Drug Delivery Reviews 2012, 64, 302-315.
19. Williams, T. L.; Johnson, B. R.; Urbanc, B.; Jenkins, A. T. A.; Connell, S. D.; Serpell, L. C., Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes. Biochemical Journal 2011, 439 (1), 67-77.
20. Imamura, R.; Shimanouchi, T.; Murata, N.; Yamashita, K.; Fukuzawa, M.; Noda, M., Detection of Fibrillization Process of Amyloid Beta Protein Using Arrayed Biosensor with Liposome Encapsulating Fluorescent Molecules. Procedia Engineering 2016, 168, 1414-1417.
21. Pillot, T.; Goethals, M.; Vanloo, B.; Talussot, C.; Brasseur, R.; Vandekerckhove, J.; Rosseneu, M.; Lins, L., Fusogenic properties of the C-terminal domain of the Alzheimer β-amyloid peptide. Journal of Biological Chemistry 1996, 271 (46), 28757-28765.
22. Calderón, R. O.; DeVries, G. H., Lipid composition and phospholipid asymmetry of membranes from a Schwann cell line. Journal of Neuroscience Research 1997, 49 (3), 372-380.
23. Bertrand, N.; Bouvet, C.; Moreau, P.; Leroux, J.-C., Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication. 2010.
24. Killian, J. A.; de Kruijff, B., Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochimica et Biophysica Acta (BBA)-Biomembranes 2004, 1666 (1), 275-288.
25. Marsh, D., Lateral pressure profile, spontaneous curvature frustration, and the incorporation and conformation of proteins in membranes. Biophysical Journal 2007, 93 (11), 3884-3899.
26. van Rooijen, B. D.; Claessens, M. M.; Subramaniam, V., Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochimica et Biophysica Acta (BBA)-Biomembranes 2009, 1788 (6), 1271-1278.
27. Haass, C.; Selkoe, D. J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer′s amyloid β-peptide. Nature Reviews Molecular Cell Biology 2007, 8 (2), 101-112.
28. Benilova, I.; Karran, E.; De Strooper, B., The toxic A [beta] oligomer and Alzheimer′s disease: an emperor in need of clothes. Nature Neuroscience 2012, 15 (3), 349.
29. Qiang, W.; Yau, W.-M.; Schulte, J., Fibrillation of β amyloid peptides in the presence of phospholipid bilayers and the consequent membrane disruption. Biochimica et Biophysica Acta (BBA)-Biomembranes 2015, 1848 (1), 266-276.
30. Gillman, A. L.; Lee, J.; Ramachandran, S.; Capone, R.; Gonzalez, T.; Wrasidlo, W.; Masliah, E.; Lal, R., Small molecule NPT-440-1 inhibits ionic flux through Aβ 1-42 pores: Implications for Alzheimer′s disease therapeutics. Nanomedicine: Nanotechnology, Biology and Medicine 2016, 12 (8), 2331-2340.
31. De Strooper, B.; Chávez Gutiérrez, L., Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer′s disease and beyond. Annual Review of Pharmacology and Toxicology 2015, 55, 419-437.
32. Doody, R. S.; Raman, R.; Farlow, M.; Iwatsubo, T.; Vellas, B.; Joffe, S.; Kieburtz, K.; He, F.; Sun, X.; Thomas, R. G., A phase 3 trial of semagacestat for treatment of Alzheimer′s disease. New England Journal of Medicine 2013, 369 (4), 341-350.
33. Jass, J.; Tjärnhage, T.; Puu, G., From liposomes to supported, planar bilayer structures on hydrophilic and hydrophobic surfaces: an atomic force microscopy study. Biophysical Journal 2000, 79 (6), 3153-3163.
34. Johnson, J. M.; Ha, T.; Chu, S.; Boxer, S. G., Early steps of supported bilayer formation probed by single vesicle fluorescence assays. Biophysical Journal 2002, 83 (6), 3371-3379.
35. Zhang-Haagen, B.; Biehl, R.; Nagel-Steger, L.; Radulescu, A.; Richter, D.; Willbold, D., Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering. PloS One 2016, 11 (2), e0150267.
36. Ryan, T. M.; Caine, J.; Mertens, H. D.; Kirby, N.; Nigro, J.; Breheney, K.; Waddington, L. J.; Streltsov, V. A.; Curtain, C.; Masters, C. L., Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. PeerJ 2013, 1, e73.
37. Allen, T.; Cleland, L., Serum-induced leakage of liposome contents. Biochimica et Biophysica Acta (BBA)-Biomembranes 1980, 597 (2), 418-426.
38. Patel, H.; Tscheka, C.; Heerklotz, H., Characterizing vesicle leakage by fluorescence lifetime measurements. Soft Matter 2009, 5 (15), 2849-2851.
39. Biancalana, M.; Koide, S., Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2010, 1804 (7), 1405-1412.
40. Groenning, M., Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status. Journal of Chemical Biology 2010, 3 (1), 1-18.
41. Korshavn, K. J.; Satriano, C.; Lin, Y.; Zhang, R.; Dulchavsky, M.; Bhunia, A.; Ivanova, M. I.; Lee, Y.-H.; La Rosa, C.; Lim, M. H., Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β. Journal of Biological Chemistry 2017, 292 (11), 4638-4650.
42. Marsh, D., Lateral pressure in membranes. Biochimica et Biophysica Acta (BBA)-Reviews on Biomembranes 1996, 1286 (3), 183-223.
43. Correcirc, D. H.; Ramos, C. H., The use of circular dichroism spectroscopy to study protein folding, form and function. African Journal of Biochemistry Research 2009, 3 (5), 164-173.
44. Pace, C. N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T., How to measure and predict the molar absorption coefficient of a protein. Protein Science 1995, 4 (11), 2411-2423.
45. Veatch, S. L.; Keller, S. L., Seeing spots: complex phase behavior in simple membranes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 2005, 1746 (3), 172-185.
46. Feigenson, G. W., Phase behavior of lipid mixtures. Nature Chemical Biology 2006, 2 (11), 560-563.
47. Ghosh, A.; Pradhan, N.; Bera, S.; Datta, A.; Krishnamoorthy, J.; Jana, N. R.; Bhunia, A., Inhibition and Degradation of Amyloid Beta (Aβ40) Fibrillation by Designed Small Pep-tide: A Combined Spectroscopy, Microscopy and Cell Toxicity Study. ACS Chemical Neuroscience 2017.
48. Richter, R. P.; Bérat, R.; Brisson, A. R., Formation of solid-supported lipid bilayers: an integrated view. Langmuir 2006, 22 (8), 3497-3505.
49. Relini, A.; Marano, N.; Gliozzi, A., Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers. Advances in Colloid and Interface Science 2014, 207, 81-92.
50. Lewis, B. A.; Engelman, D. M., Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. Journal of Molecular Biology 1983, 166 (2), 211-217.
51. Han, C.-T.; Chao, L., Creating Air-Stable Supported Lipid Bilayers by Physical Confinement Induced by Phospholipase A2. ACS Applied Materials & Interfaces 2014, 6 (9), 6378-6383.
52. Connelly, L.; Jang, H.; Teran Arce, F.; Ramachandran, S.; Kagan, B. L.; Nussinov, R.; Lal, R., Effects of point substitutions on the structure of toxic Alzheimer’s β-amyloid channels: atomic force microscopy and molecular dynamics simulations. Biochemistry 2012, 51 (14), 3031-3038.
53. Lin, H.; Bhatia, R.; Lal, R., Amyloid β protein forms ion channels: implications for Alzheimer’s disease pathophysiology. The FASEB Journal 2001, 15 (13), 2433-2444.
54. Quist, A.; Doudevski, I.; Lin, H.; Azimova, R.; Ng, D.; Frangione, B.; Kagan, B.; Ghiso, J.; Lal, R., Amyloid ion channels: a common structural link for protein-misfolding disease. Proceedings of the National Academy of Sciences of the United States of America 2005, 102 (30), 10427-10432.
55. Szekely, P.; Dvir, T.; Asor, R.; Resh, R.; Steiner, A.; Szekely, O.; Ginsburg, A.; Mosenkis, J.; Guralnick, V.; Dan, Y., Effect of temperature on the structure of charged membranes. The Journal of Physical Chemistry B 2011, 115 (49), 14501-14506.
56. Shimanouchi, T.; Ishii, H.; Yoshimoto, N.; Umakoshi, H.; Kuboi, R., Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization. Colloids and Surfaces B: Biointerfaces 2009, 73 (1), 156-160.
57. London, E.; Brown, D. A., Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochimica et Biophysica Acta (BBA)-Biomembranes 2000, 1508 (1), 182-195.
58. Huang, H. W.; Chen, F.-Y.; Lee, M.-T., Molecular mechanism of peptide-induced pores in membranes. Physical Review Letters 2004, 92 (19), 198304.
59. Johannes, L.; Mayor, S., Induced domain formation in endocytic invagination, lipid sorting, and scission. Cell 2010, 142 (4), 507-510.
60. Heberle, F. A.; Petruzielo, R. S.; Pan, J.; Drazba, P.; Kučerka, N.; Standaert, R. F.; Feigenson, G. W.; Katsaras, J., Bilayer thickness mismatch controls domain size in model membranes. Journal of the American Chemical Society 2013, 135 (18), 6853-6859.
61. Williams, T. L.; Day, I. J.; Serpell, L. C., The effect of Alzheimer’s Aβ aggregation state on the permeation of biomimetic lipid vesicles. Langmuir 2010, 26 (22), 17260-17268.
62. Legleiter, J.; Fryer, J. D.; Holtzman, D. M.; Kowalewski, T., The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption. ACS Chemical Neuroscience 2011, 2 (10), 588-599.
63. Lee, M.-T.; Chen, F.-Y.; Huang, H. W., Energetics of pore formation induced by membrane active peptides. Biochemistry 2004, 43 (12), 3590-3599.
64. Yang, L.; Harroun, T. A.; Weiss, T. M.; Ding, L.; Huang, H. W., Barrel-stave model or toroidal model? A case study on melittin pores. Biophysical Journal 2001, 81 (3), 1475-1485.
65. Rouser, G.; Yamamoto, A., Curvilinear regression course of human brain lipid composition changes with age. Lipids 1968, 3 (3), 284-287.
66. Prinetti, A.; Chigorno, V.; Prioni, S.; Loberto, N.; Marano, N.; Tettamanti, G.; Sonnino, S., Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. Journal of Biological Chemistry 2001, 276 (24), 21136-21145. |